145 related articles for article (PubMed ID: 33414468)
1. BTF3 confers oncogenic activity in prostate cancer through transcriptional upregulation of Replication Factor C.
Zhang Y; Gao X; Yi J; Sang X; Dai Z; Tao Z; Wang M; Shen L; Jia Y; Xie D; Cheng H; Liu Z; Liu P
Cell Death Dis; 2021 Jan; 12(1):12. PubMed ID: 33414468
[TBL] [Abstract][Full Text] [Related]
2. Basic transcription factor 3 (BTF3) regulates transcription of tumor-associated genes in pancreatic cancer cells.
Kusumawidjaja G; Kayed H; Giese N; Bauer A; Erkan M; Giese T; Hoheise JD; Friess H; Kleeff J
Cancer Biol Ther; 2007 Mar; 6(3):367-76. PubMed ID: 17312387
[TBL] [Abstract][Full Text] [Related]
3. BTF3 sustains cancer stem-like phenotype of prostate cancer via stabilization of BMI1.
Hu J; Sun F; Chen W; Zhang J; Zhang T; Qi M; Feng T; Liu H; Li X; Xing Y; Xiong X; Shi B; Zhou G; Han B
J Exp Clin Cancer Res; 2019 May; 38(1):227. PubMed ID: 31138311
[TBL] [Abstract][Full Text] [Related]
4. Basic Transcription Factor 3 Is Required for Proliferation and Epithelial-Mesenchymal Transition via Regulation of FOXM1 and JAK2/STAT3 Signaling in Gastric Cancer.
Zhang DZ; Chen BH; Zhang LF; Cheng MK; Fang XJ; Wu XJ
Oncol Res; 2017 Nov; 25(9):1453-1462. PubMed ID: 28276310
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of BTF3 sensitizes luminal breast cancer cells to PI3Kα inhibition through the transcriptional regulation of ERα.
Ding J; Wang X; Zhang Y; Sang X; Yi J; Liu C; Liu Z; Wang M; Zhang N; Xue Y; Shen L; Zhao W; Luo F; Liu P; Cheng H
Cancer Lett; 2019 Jan; 440-441():54-63. PubMed ID: 30315845
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of BTF3 affects the proliferation, apoptosis, and cell cycle regulation in hypopharyngeal squamous cell carcinoma.
Zhang Y; Gross N; Li Z; Yin G; Zhong Q; Liu C; Huang Z
Biomed Pharmacother; 2019 Oct; 118():109211. PubMed ID: 31404775
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological significance of BTF3 expression in colorectal cancer.
Wang CJ; Frånbergh-Karlson H; Wang DW; Arbman G; Zhang H; Sun XF
Tumour Biol; 2013 Aug; 34(4):2141-6. PubMed ID: 23532689
[TBL] [Abstract][Full Text] [Related]
8. Quantitative analysis of BTF3, HINT1, NDRG1 and ODC1 protein over-expression in human prostate cancer tissue.
Symes AJ; Eilertsen M; Millar M; Nariculam J; Freeman A; Notara M; Feneley MR; Patel HR; Masters JR; Ahmed A
PLoS One; 2013; 8(12):e84295. PubMed ID: 24386364
[TBL] [Abstract][Full Text] [Related]
9. Sequencing and expression of complementary DNA for the general transcription factor BTF3.
Zheng XM; Black D; Chambon P; Egly JM
Nature; 1990 Apr; 344(6266):556-9. PubMed ID: 2320128
[TBL] [Abstract][Full Text] [Related]
10. BTF3 is a potential new substrate of protein kinase CK2.
Grein S; Pyerin W
Mol Cell Biochem; 1999 Jan; 191(1-2):121-8. PubMed ID: 10094400
[TBL] [Abstract][Full Text] [Related]
11. Positive expression of basic transcription factor 3 predicts poor survival of colorectal cancer patients: possible mechanisms involved.
Liu Q; Wu J; Lu T; Fang Z; Huang Z; Lu S; Dai C; Li M
Cell Death Dis; 2019 Jul; 10(7):509. PubMed ID: 31263147
[TBL] [Abstract][Full Text] [Related]
12. BTF3 promotes stemness and inhibits TypeⅠInterferon signaling pathway in triple-negative breast cancer.
Wang H; Gao L; Qi M; Su P; Xiong X; Zhao J; Hu J; Han B
Biochem Biophys Res Commun; 2021 Jan; 537():22-28. PubMed ID: 33383560
[TBL] [Abstract][Full Text] [Related]
13. Genomic structure of the putative BTF3 transcription factor.
Kanno M; Chalut C; Egly JM
Gene; 1992 Aug; 117(2):219-28. PubMed ID: 1386332
[TBL] [Abstract][Full Text] [Related]
14. Protein arginine methyltransferase 5 functions as an epigenetic activator of the androgen receptor to promote prostate cancer cell growth.
Deng X; Shao G; Zhang HT; Li C; Zhang D; Cheng L; Elzey BD; Pili R; Ratliff TL; Huang J; Hu CD
Oncogene; 2017 Mar; 36(9):1223-1231. PubMed ID: 27546619
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-101 regulated transcriptional modulator SUB1 plays a role in prostate cancer.
Chakravarthi BV; Goswami MT; Pathi SS; Robinson AD; Cieślik M; Chandrashekar DS; Agarwal S; Siddiqui J; Daignault S; Carskadon SL; Jing X; Chinnaiyan AM; Kunju LP; Palanisamy N; Varambally S
Oncogene; 2016 Dec; 35(49):6330-6340. PubMed ID: 27270442
[TBL] [Abstract][Full Text] [Related]
16. A Novel Mechanism Driving Poor-Prognosis Prostate Cancer: Overexpression of the DNA Repair Gene, Ribonucleotide Reductase Small Subunit M2 (RRM2).
Mazzu YZ; Armenia J; Chakraborty G; Yoshikawa Y; Coggins SA; Nandakumar S; Gerke TA; Pomerantz MM; Qiu X; Zhao H; Atiq M; Khan N; Komura K; Lee GM; Fine SW; Bell C; O'Connor E; Long HW; Freedman ML; Kim B; Kantoff PW
Clin Cancer Res; 2019 Jul; 25(14):4480-4492. PubMed ID: 30996073
[TBL] [Abstract][Full Text] [Related]
17. miR‑802 inhibits the epithelial‑mesenchymal transition, migration and invasion of cervical cancer by regulating BTF3.
Wu X; Liu L; Zhang H
Mol Med Rep; 2020 Sep; 22(3):1883-1891. PubMed ID: 32582971
[TBL] [Abstract][Full Text] [Related]
18. Exploring the roles of basal transcription factor 3 in eukaryotic growth and development.
Jamil M; Wang W; Xu M; Tu J
Biotechnol Genet Eng Rev; 2015; 31(1-2):21-45. PubMed ID: 26428578
[TBL] [Abstract][Full Text] [Related]
19. Interaction between transcription factor, basal transcription factor 3, and the NH2-terminal domain of human estrogen receptor alpha.
Green CD; Thompson PD; Johnston PG; El-Tanani MK
Mol Cancer Res; 2007 Nov; 5(11):1191-200. PubMed ID: 18025262
[TBL] [Abstract][Full Text] [Related]
20. Basic transcription factor 3 expression silencing attenuates colon cancer cell proliferation and migration
Li X; Sui J; Xing J; Cao F; Wang H; Fu C; Wang H
Oncol Lett; 2019 Jan; 17(1):113-118. PubMed ID: 30655745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
